Obesity
RecruitingStudy on Semaglutide and Low Energy Diet for Obesity in Adolescents Aged 12-17
- Disease:Obesity
- Substances:Semaglutide
Norway- Participants:0–17 years
- Substances:Semaglutide
- Sponsor:Vestfold Hospital Trust
Rare diseases
Investigational molecules
Locations
P. O. Box 2168, 3103 Tonsberg, Norway
Vestfold Hospital Trust’s research activity is centred on obesity care for treatment-seeking adolescents, with interest in body weight reduction, body mass index change, and clinical management of severe excess weight in young people.
The sponsor’s clinical focus includes structured care for adolescents with obesity who are seeking treatment in a hospital-based setting.
Vestfold Hospital Trust runs clinical trials in conditions such as Obesity, among others.
Clinical trials run by this sponsor – those enrolling participants first.
NorwayIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.